Jinlan Luo
Overview
Explore the profile of Jinlan Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Dong W, Yang H, Sun P, Luo J, Kong F, et al.
Anal Methods
. 2024 Nov;
16(48):8419-8426.
PMID: 39552364
Viscosity is a crucial indicator of the flow state of proteins, lipids, and polysaccharides in the cell microenvironment and plays a vital role in maintaining normal cellular activities. Abnormal viscosity...
2.
Luo J, Song C, Chen Y, Liu K
Chem Biomed Imaging
. 2024 Oct;
2(6):422-431.
PMID: 39474516
Blood viscosity changes and blood clots are high-impact diseases, but the pathogenic mechanisms and detection methods are still limited. Due to the complexity of the cellular microenvironment, viscosity is a...
3.
Song C, Luo J, Gao C, Peng Q, Gibril M, Fatehi P, et al.
Int J Biol Macromol
. 2024 Jun;
273(Pt 2):132640.
PMID: 38825280
The high energy density and robust cycle properties of lithium-ion batteries contribute to their extensive range of applications. Polyolefin separators are often used for the purpose of storing electrolytes, hence...
4.
Chen Y, Zong P, Chen Q, Wang X, Luo J, Liu K, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2024 May;
319:124527.
PMID: 38815313
Viscosity is a parameter used to measure the fluidity of liquids and a key indicator in evaluating the states of body fluid in biological tissues and lesions. Most traditional detection...
5.
Shi L, Wei X, Luo J, Tu L
Front Cardiovasc Med
. 2024 May;
11:1339094.
PMID: 38803667
Objective: To investigate the causal role of venous thrombolism mediating sodium-glucose cotransporter 2 (SGLT2) inhibition in death due to cardiac causes using Mendelian randomization (MR). Methods: A two-sample two-step MR...
6.
Luo J, Tu L, Zhou C, Li G, Shi L, Hu S
Sleep Med
. 2024 May;
119:480-487.
PMID: 38795402
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) initially emerged as oral antidiabetic medication but were subsequently discovered to exhibit pleiotropic actions. Insomnia is a prevalent and debilitating sleep disorder. To date,...
7.
Luo J, Hu S, Liu J, Shi L, Luo L, Li W, et al.
Cell Mol Life Sci
. 2024 May;
81(1):228.
PMID: 38777955
Diabetic cardiomyopathy (DCM) is a prevalent complication of type 2 diabetes (T2D). 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) is a glycolysis regulator. However, the potential effects of PFKFB3 in the DCM remain unclear....
8.
Luo J, Shi L, Liu J, Li G, Tu L, Hu S
Front Cardiovasc Med
. 2024 May;
11:1371513.
PMID: 38725835
Objective: To investigate the causal contributions of Sodium-glucose cotransporter 2 (SGLT2) inhibition on Heart Failure (HF) and identify the circulating proteins that mediate SGLT2 inhibition's effects on HF. Methods: Applying...
9.
Shi L, Li G, Hou N, Tu L, Li J, Luo J, et al.
Eur J Pharmacol
. 2024 Apr;
976:176619.
PMID: 38679119
Aims: Sodium-glucose cotransporter 2 (SGLT2) inhibitors offer a novel therapeutic avenue for myocardial infarction (MI). However, the exact nature of this relationship and the underlying mechanisms are not fully understood....
10.
Shi L, Luo J, Wei X, Xu X, Tu L
Front Pharmacol
. 2024 Mar;
15:1327033.
PMID: 38469409
Ginsenoside Rg3, a compound derived from C. A. Mey., is increasingly recognized for its wide range of pharmacological effects. Under the worldwide healthcare challenges posed by heart diseases, Rg3 stands...